Agents that stabilise atherosclerotic plaque

Author： Chiong Jun R   Miller Alan B  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.10, 2003-10, pp. : 1681-1692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-invasive imaging of plaque vulnerability: an important tool for the assessment of agents to stabilise atherosclerotic plaques

By Sosnovik David E   Muller James E   Brady Thomas J   Kathiresan Sekar  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 5, 2002-05 ,pp. : 693-704

Informa Healthcare

Access to resources Recommend Favorite

The vulnerable atherosclerotic plaque

By Suckling K.E.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 121-134

Informa Healthcare

Access to resources Recommend Favorite

Atherosclerotic Plaque Regression: Fact or Fiction?

By Shanmugam Nesan   Román-Rego Ana   Ong Peter   Kaski Juan  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 311-317

Springer Publishing Company

Access to resources Recommend Favorite

Atorvastatin induces atherosclerotic plaque regression

By  

Inpharma, Vol. 1, Iss. 1484, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Statin Treatment and Progression of Atherosclerotic Plaque Burden

By Grobbee D.E.   Bots M.L.  

Drugs, Vol. 63, Iss. 9, 2003-01 ,pp. : 893-911

Adis International

Access to resources Recommend Favorite